Form D · Other Health Care

Metagenics, Inc.

San Clemente, CA · CIK 0001352778

Offering snapshot reported Sep 18, 2009 · SEC filing

Reported sold
$28.1M
Offering amount: $28.1M
Investors reported
1
Form D · investor count
Minimum accepted
$0
Reported outside-investor minimum
First sale
Sep 11, 2009
As reported in this filing

Fundraising history

Reported sold
Reported amount sold by Form D filing date$0$14.1M$28.1MSep 18, 2009: $28,100,000.00Sep 18, 2009Sep 18, 2009: $28,100,000.00Sep 18, 2009

Dates are filing dates, not cash receipt dates. Decreases are reported revisions, not evidence of withdrawals. Separate offering histories are not added together.

What changed?

Latest filing versus its linked predecessor, where available.

No comparable changes in the displayed metrics.

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Sep 18, 2009Amendment$28,100,000$0vs Sep 18, 20091SEC filing
Sep 18, 2009Initial$28,100,000No comparison1SEC filing

Offering details

Securities
Not reported
Exemptions
06
Duration over one year
No
Business combination
Yes
Sales commissions
$0
Finders' fees
$0
Form D file number
021-134554
1,878,255 shares of Metagenics, Inc. Common Stock

Source: Form D, filed Sep 18, 2009. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Jeffrey Bland Director, Executive
Yee Ping ` Chu Director
David Fetah Executive
Robert Hovee Director
Jeffrey Katke Director, Executive
Paul Konney Executive
David Krajanowski Director
Michael Leiner Director
Jerry Morey Executive
John Zaepfel Director

Issuer details

Industry: Other Health Care (See others in industry)

Address:
100 Avenida La Pata
San Clemente, CA, 92673